VINCA ALKALOID TOXICITY
Tracking # 20-837223
$99999.00
There are no ratings for this course
Learn more Educator STATPEARLS PUBLISHING, LLC
CE Broker Reporting Reported automatically
Method Computer-Based Training
Course overview
VINCA ALKALOIDS, WHICH BELONG TO A CLASS OF CELL CYCLE PHASE M SPECIFIC ANTI-TUBULIN AGENTS ARE ONE OF THE FIRST PLANT ALKALOIDS TO BE DEVELOPED FOR USE AS ANTI-CANCER AGENTS IN HUMANS. THIS ACTIVITY DESCRIBES THE INCIDENCE, ETIOLOGY, CLINICAL FEATURES, EXAMINATION FINDINGS, DIFFERENTIAL DIAGNOSIS, ASSESSMENT, AND MANAGEMENT OF SYSTEMIC EFFECTS OF VINCA ALKALOIDS, WITH AN EMPHASIS ON VINCRISTINE-INDUCED NEUROTOXICITY.
Subject areas
This course counts toward the state boards and subject areas below.
Florida Board of Osteopathic Medicine
Osteopathic Physician
1h
General